Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, confirming an ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

FDA and Novo Nordisk are testing the seized products and do not yet have information about the drugs' identity, quality, or safety. FDA said the needles ... products are the pen label ...

Novo Nordisk has signed off on a $285 million biobucks deal with fellow Denmark-based company Ascendis Pharma to help the Wegovy manufacturer develop a once-monthly GLP-1 receptor agonist.

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

The regulator assured that it was testing the seized products with Novo Nordisk ... FDA said the pen label, carton, information for patients and health care professionals, and needles that ...